Mechanism of relaxations to C-type natriuretic peptide in veins

Michelle Banks, Chi Ming Wei, Cheol H. Kim, John C Jr. Burnett, Virginia M Miller

Research output: Contribution to journalArticle

Abstract

C-type natriuretic peptide (CNP) is an endothelium-derived peptide that shares structural homology with atrial natriuretic peptide (ANP). CNP causes greater endothelium-independent relaxations in veins compared with arteries. Relaxations to CNP in porcine coronary arteries are mediated by hyperpolarization of the smooth muscle membrane. Experiments were designed to investigate the mechanism(s) by which CNP causes relaxation in canine femoral veins. Rings of canine femoral veins without endothelium were suspended for measurement of isometric force in organ chambers. Concentration-response curves to CNP were obtained in veins contracted with either endothelin-1 (10-8 M), KCl (40 mM), phenylephrine (10-6 M) or prostaglandin F(2α) (2 x 10-6 M) in the absence and presence of BQ-123 (10-6 M), N(G)- monomenthyl-L-arginine (L-NMMA; 10-4 M), HS-142-1 (10-5 M), methylene blue (10-5 M), or potassium channel blockers, tetraethylammonium chloride (TEA; 10-3 M), charybdotoxin (10-7 M), glibenclamide (10-7 M), or apamin (10-7 M). Relaxations to CNP were significantly attenuated when the tissue was contracted with KCl and endothelin-1. During contraction to either phenylephrine or prostaglandin F(2α), relaxations to CNP were inhibited by HS-142-1, methylene blue, TEA, and charybdotoxin, but not by L-NMMA, glibenclamide, or apamin. In separate experiments, guanosine 3',5'-cyclic monophosphate increased twofold within 10-60 s after the addition of CNP (10-8 M). These data suggest that CNP mediates relaxation of canine femoral veins through activation of large-conduction, calcium-activated potassium channels and activation of particulate and soluble guanylate cyclase.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume271
Issue number5 40-5
StatePublished - Nov 1996

Fingerprint

C-Type Natriuretic Peptide
Veins
Femoral Vein
Charybdotoxin
Endothelium
Apamin
omega-N-Methylarginine
Canidae
Glyburide
Methylene Blue
Phenylephrine
Endothelin-1
Potassium Channel Blockers
Calcium-Activated Potassium Channels
Tetraethylammonium
Cyclic GMP
Prostaglandins F
Atrial Natriuretic Factor
Smooth Muscle
Arginine

Keywords

  • canine femoral veins
  • guanosine 3',5'-cyclic monophosphate
  • hyperpolarization

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Mechanism of relaxations to C-type natriuretic peptide in veins. / Banks, Michelle; Wei, Chi Ming; Kim, Cheol H.; Burnett, John C Jr.; Miller, Virginia M.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 271, No. 5 40-5, 11.1996.

Research output: Contribution to journalArticle

@article{2c7fd0565b9e4f4cb309f4fd90555886,
title = "Mechanism of relaxations to C-type natriuretic peptide in veins",
abstract = "C-type natriuretic peptide (CNP) is an endothelium-derived peptide that shares structural homology with atrial natriuretic peptide (ANP). CNP causes greater endothelium-independent relaxations in veins compared with arteries. Relaxations to CNP in porcine coronary arteries are mediated by hyperpolarization of the smooth muscle membrane. Experiments were designed to investigate the mechanism(s) by which CNP causes relaxation in canine femoral veins. Rings of canine femoral veins without endothelium were suspended for measurement of isometric force in organ chambers. Concentration-response curves to CNP were obtained in veins contracted with either endothelin-1 (10-8 M), KCl (40 mM), phenylephrine (10-6 M) or prostaglandin F(2α) (2 x 10-6 M) in the absence and presence of BQ-123 (10-6 M), N(G)- monomenthyl-L-arginine (L-NMMA; 10-4 M), HS-142-1 (10-5 M), methylene blue (10-5 M), or potassium channel blockers, tetraethylammonium chloride (TEA; 10-3 M), charybdotoxin (10-7 M), glibenclamide (10-7 M), or apamin (10-7 M). Relaxations to CNP were significantly attenuated when the tissue was contracted with KCl and endothelin-1. During contraction to either phenylephrine or prostaglandin F(2α), relaxations to CNP were inhibited by HS-142-1, methylene blue, TEA, and charybdotoxin, but not by L-NMMA, glibenclamide, or apamin. In separate experiments, guanosine 3',5'-cyclic monophosphate increased twofold within 10-60 s after the addition of CNP (10-8 M). These data suggest that CNP mediates relaxation of canine femoral veins through activation of large-conduction, calcium-activated potassium channels and activation of particulate and soluble guanylate cyclase.",
keywords = "canine femoral veins, guanosine 3',5'-cyclic monophosphate, hyperpolarization",
author = "Michelle Banks and Wei, {Chi Ming} and Kim, {Cheol H.} and Burnett, {John C Jr.} and Miller, {Virginia M}",
year = "1996",
month = "11",
language = "English (US)",
volume = "271",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "5 40-5",

}

TY - JOUR

T1 - Mechanism of relaxations to C-type natriuretic peptide in veins

AU - Banks, Michelle

AU - Wei, Chi Ming

AU - Kim, Cheol H.

AU - Burnett, John C Jr.

AU - Miller, Virginia M

PY - 1996/11

Y1 - 1996/11

N2 - C-type natriuretic peptide (CNP) is an endothelium-derived peptide that shares structural homology with atrial natriuretic peptide (ANP). CNP causes greater endothelium-independent relaxations in veins compared with arteries. Relaxations to CNP in porcine coronary arteries are mediated by hyperpolarization of the smooth muscle membrane. Experiments were designed to investigate the mechanism(s) by which CNP causes relaxation in canine femoral veins. Rings of canine femoral veins without endothelium were suspended for measurement of isometric force in organ chambers. Concentration-response curves to CNP were obtained in veins contracted with either endothelin-1 (10-8 M), KCl (40 mM), phenylephrine (10-6 M) or prostaglandin F(2α) (2 x 10-6 M) in the absence and presence of BQ-123 (10-6 M), N(G)- monomenthyl-L-arginine (L-NMMA; 10-4 M), HS-142-1 (10-5 M), methylene blue (10-5 M), or potassium channel blockers, tetraethylammonium chloride (TEA; 10-3 M), charybdotoxin (10-7 M), glibenclamide (10-7 M), or apamin (10-7 M). Relaxations to CNP were significantly attenuated when the tissue was contracted with KCl and endothelin-1. During contraction to either phenylephrine or prostaglandin F(2α), relaxations to CNP were inhibited by HS-142-1, methylene blue, TEA, and charybdotoxin, but not by L-NMMA, glibenclamide, or apamin. In separate experiments, guanosine 3',5'-cyclic monophosphate increased twofold within 10-60 s after the addition of CNP (10-8 M). These data suggest that CNP mediates relaxation of canine femoral veins through activation of large-conduction, calcium-activated potassium channels and activation of particulate and soluble guanylate cyclase.

AB - C-type natriuretic peptide (CNP) is an endothelium-derived peptide that shares structural homology with atrial natriuretic peptide (ANP). CNP causes greater endothelium-independent relaxations in veins compared with arteries. Relaxations to CNP in porcine coronary arteries are mediated by hyperpolarization of the smooth muscle membrane. Experiments were designed to investigate the mechanism(s) by which CNP causes relaxation in canine femoral veins. Rings of canine femoral veins without endothelium were suspended for measurement of isometric force in organ chambers. Concentration-response curves to CNP were obtained in veins contracted with either endothelin-1 (10-8 M), KCl (40 mM), phenylephrine (10-6 M) or prostaglandin F(2α) (2 x 10-6 M) in the absence and presence of BQ-123 (10-6 M), N(G)- monomenthyl-L-arginine (L-NMMA; 10-4 M), HS-142-1 (10-5 M), methylene blue (10-5 M), or potassium channel blockers, tetraethylammonium chloride (TEA; 10-3 M), charybdotoxin (10-7 M), glibenclamide (10-7 M), or apamin (10-7 M). Relaxations to CNP were significantly attenuated when the tissue was contracted with KCl and endothelin-1. During contraction to either phenylephrine or prostaglandin F(2α), relaxations to CNP were inhibited by HS-142-1, methylene blue, TEA, and charybdotoxin, but not by L-NMMA, glibenclamide, or apamin. In separate experiments, guanosine 3',5'-cyclic monophosphate increased twofold within 10-60 s after the addition of CNP (10-8 M). These data suggest that CNP mediates relaxation of canine femoral veins through activation of large-conduction, calcium-activated potassium channels and activation of particulate and soluble guanylate cyclase.

KW - canine femoral veins

KW - guanosine 3',5'-cyclic monophosphate

KW - hyperpolarization

UR - http://www.scopus.com/inward/record.url?scp=0029853406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029853406&partnerID=8YFLogxK

M3 - Article

C2 - 8945908

VL - 271

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 5 40-5

ER -